Triple Negative Breast Cancer Drug Development Summit
Evvnt Promotion / evvnt
Archivio
28.04.2021 - 29.04.2021 Virtual
Time: 08:00 to 16:00
Temi della conferenza
This is the primary industry platform specifically dedicated to providing you insight into the latest developments of safe and efficacious blockbuster therapies to treat triple negative breast cancer.
Breast cancer (BC) is the most common solid tumor in women, with the triple negative subtype associated with poorer overall survival and a higher probability of cancer recurrence.
This is the primary industry platform specifically dedicated to providing you insight into the latest developments of safe and efficacious blockbuster therapies to treat triple negative breast cancer.
Breast cancer (BC) is the most common solid tumor in women, with the triple negative subtype associated with poorer overall survival and a higher probability of cancer recurrence.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/729098-2?pid=4832
Speakers: Alison L. Hannah, Senior Vice President and Chief Medical Officer, CytomX Therapeutics, Angus Sinclair, VP Immuno-Oncology, IGM Biosciences, and more.
Brochure: https://go.evvnt.com/729098-2?pid=4832
Speakers: Alison L. Hannah, Senior Vice President and Chief Medical Officer, CytomX Therapeutics, Angus Sinclair, VP Immuno-Oncology, IGM Biosciences, and more.
Informazioni ed Iscrizioni:
https://go.evvnt.com/729098-1?pid=4832
Mr. Customer Services
Oncologia
Lingua
Inglese
Inglese
Quote del Congresso
Conference Only (Drug Developer Pricing): USD 1999.00, Conference Only (Service Provider Pricing): USD 2499.00, Conference Only (Academic Pricing): USD 1799.00
Conference Only (Drug Developer Pricing): USD 1999.00, Conference Only (Service Provider Pricing): USD 2499.00, Conference Only (Academic Pricing): USD 1799.00
I partecipanti attesi
1000 - 1000
1000 - 1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
